Mucinex FastMax Caplets Cold Flu Recalled for Improper Storage Conditions
Family Dollar Stores is recalling Mucinex FastMax Caplets Cold Flu 4CT (SKU 903372) distributed nationwide from April to June 2022 due to improper storage temperature conditions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for a manufacturing practice deviation involving improper medication storage, which represents a risk-of-harm scenario. No illnesses or injuries have been reported.
Plain-English summary
Family Dollar Stores, LLC is recalling Mucinex FastMax Caplets Cold Flu 4CT (SKU 903372) distributed to select Family Dollar locations nationwide between April 30, 2022 and June 10, 2022. The product was held outside the appropriate storage temperature conditions, a deviation from FDA Current Good Manufacturing Practice (CGMP) standards.
No illnesses or injuries have been reported. Consumers who purchased this product should contact Family Dollar Stores for information about returning the medication for a refund or replacement.
The recalled product
- Product
- MUCINEX FASTMAX CAPLETS COLD FLU 4CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Cold and Cough Medication
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 903372
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01